About 1 Trademarks found that are owned by Billings Pharmaceuticals Inc.
Filters
Mark
Details
Status
Class/Description
BILLINGSPHARMACEUTICALS
BILLINGS PHARMACEUTICALS INC.
75240211
11 Feb 1997
Dead/Abandoned
on 22 Jun 2000
pharmaceutical preparations for reducing rejection of transplanted org...
Class 005
Class 005
Pharmaceutical Products
pharmaceutical preparations for reducing rejection of transplanted organs and tissue; pharmaceutical preparations for potentiating the effects of antiviral therapeutics; pharmaceutical preparations for antimetastatic treatment of cancer; vaccines; medical diagnostic reagents; antibodies for in vitro scientific or research use; diagnostic preparations for clinical, research or medical laboratory use; chemical products for medical use, namely, antiviral agents and solutions for reperfusion and preservation of tissue and organs for medical use
pharmaceutical preparations for reducing rejection of transplanted organs and tissue; pharmaceutical preparations for potentiating the effects of antiviral therapeutics; pharmaceutical preparations for antimetastatic treatment of cancer; vaccines; medical diagnostic reagents; antibodies for in vitro scientific or research use; diagnostic preparations for clinical, research or medical laboratory use; chemical products for medical use, namely, antiviral agents and solutions for reperfusion and preservation of tissue and organs for medical use
Dead/Abandoned
on 22 Jun 2000
BILLINGSPHARMACEUTICALS
BILLINGS PHARMACEUTICALS INC.
75240211 · 11 Feb 1997
005
Class 005
Pharmaceutical Products
pharmaceutical preparations for reducing rejection of transplanted organs and tissue; pharmaceutical preparations for potentiating the effects of antiviral therapeutics; pharmaceutical preparations for antimetastatic treatment of cancer; vaccines; medical diagnostic reagents; antibodies for in vitro scientific or research use; diagnostic preparations for clinical, research or medical laboratory use; chemical products for medical use, namely, antiviral agents and solutions for reperfusion and preservation of tissue and organs for medical use
pharmaceutical preparations for reducing rejection of transplanted organs and tissue; pharmaceutical preparations for potentiating the effects of antiviral therapeutics; pharmaceutical preparations for antimetastatic treatment of cancer; vaccines; medical diagnostic reagents; antibodies for in vitro scientific or research use; diagnostic preparations for clinical, research or medical laboratory use; chemical products for medical use, namely, antiviral agents and solutions for reperfusion and preservation of tissue and organs for medical use
pharmaceutical preparations for reducing rejection of transplanted org...